Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Clinical results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring for liver tumors using a gimbal-mounted linac: A multi-institutional phase II study.
Authors
Yusuke Iizuka
Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan
Yusuke Iizuka , Masahiro Hiraoka , Masaki Kokubo , Takashi Sakamoto , Katsuyuki Karasawa , Keiko Murofushi , Mitsuhiro Nakamura , Yukinori Matsuo , Satoshi Morita , Haruo Inokuchi , Takashi Mizowaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
UMIN000017886
DOI
10.1200/JCO.2022.40.4_suppl.441
Abstract #
441
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
The role of stereotactic body radiation therapy using the CyberKnife system in limited hepatic metastases.
First Author: Eman ElAlfy
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial of combination of PD-1 immune checkpoint inhibition with all-lesion stereotactic radiation (SBRT) in oligometastatic renal cell carcinoma (omRCC).
First Author: Jing Liu
Poster
2021 ASCO Annual Meeting
Phase I trial of acoustic cluster therapy (ACT) with chemotherapy in patients with liver metastases of gastrointestinal origin (ACTIVATE study).
First Author: Udai Banerji
Poster
2018 ASCO Annual Meeting
A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403)—Long term follow-up results.
First Author: Yasushi Nagata